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Crystal structure of RNA 3′-terminal phosphate cyclase, a
ubiquitous enzyme with unusual topology
Gottfried J Palm1†, Eric Billy2, Witold Filipowicz2 and Alexander Wlodawer1*
Background: RNA cyclases are a family of RNA-modifying enzymes that are
conserved in eucarya, bacteria and archaea. They catalyze the ATP-dependent
conversion of the 3′-phosphate to the 2′,3′-cyclic phosphodiester at the end of
RNA, in a reaction involving formation of the covalent AMP–cyclase
intermediate. These enzymes might be responsible for production of the cyclic
phosphate RNA ends that are known to be required by many RNA ligases in
both prokaryotes and eukaryotes.
Results: The high-resolution structure of the Escherichia coli RNA 3′-terminal
phosphate cyclase was determined using multiwavelength anomalous
diffraction. Two orthorhombic crystal forms of E. coli cyclase (space group
P212121 and P21212) were used to solve and refine the structure to 2.1 Å
resolution (R factor 20.4%; Rfree 27.6%). Each molecule of RNA cyclase
consists of two domains. The larger domain contains three repeats of a folding
unit comprising two parallel α helices and a four-stranded β sheet; this fold was
previously identified in translation initiation factor 3 (IF3). The large domain is
similar to one of the two domains of 5-enolpyruvylshikimate-3-phosphate
synthase and UDP–N-acetylglucosamine enolpyruvyl transferase. The smaller
domain uses a similar secondary structure element with different topology,
observed in many other proteins such as thioredoxin.
Conclusions: The fold of RNA cyclase consists of known elements connected
in a new and unique manner. Although the active site of this enzyme could not
be unambiguously assigned, it can be mapped to a region surrounding His309,
an adenylate acceptor, in which a number of amino acids are highly conserved
in the enzyme from different sources. The structure of E. coli cyclase will be
useful for interpretation of structural and mechanistic features of this and other
related enzymes.
Introduction
Terminal 2′,3′-cyclic phosphates are produced during
RNA cleavage by many endoribonucleases, as either inter-
mediates or final products of the reaction (reviewed in
[1–3]). Sekiguchi and Shuman [4] have shown recently
that the type I topoisomerase has endoribonuclease activ-
ity, thereby producing 2′,3′-cyclic phosphate ends, too.
Moreover, the RNA-based enzymes such as the hammer-
head, hairpin or hepatitis delta ribozymes, generate cyclic
phosphate termini (reviewed in [5]). Interest in the
2′,3′-cyclic phosphate has heightened when it was found
that two eukaryotic RNA ligases involved in tRNA splic-
ing require cyclic ends for RNA ligation [6–13]; reviewed
in [3,12,14,15]. One of these RNA ligases, an enzyme gen-
erating the 3′,5′-phosphodiester, 2′-phosphomonoester
linkage, also functions in the splicing of the unusual intron
present in HAC1 pre-mRNA in yeast [16] and might be
involved in the circularization of virusoid and viroid RNAs
in plants (reviewed in [17,18]). Furthermore, the only
known cellular eubacterial RNA ligase, an enzyme that
joins RNA ends via the atypical 2′,5′-phosphodiester, also
requires 2′,3′-cyclic termini. Physiological substrates of
this ligase are not known [18,19].
Discovery of the RNA 3′-terminal phosphate cyclase indi-
cated that endonucleolytic cleavage is not the only mecha-
nism to generate 2′,3′-cyclic-phosphate-terminated RNAs.
The cyclase, originally identified in extracts of HeLa cells
and Xenopus oocytes, catalyzes the conversion of a 3′-phos-
phomonoester at the end of RNA to the 2′,3′-cyclic diester
in a reaction dependent on ATP [7,8]. The cyclase has been
purified from HeLa cell extracts and its cDNA has been
cloned recently [20,21]. Ubiquitously expressed in all mam-
malian tissues and cell lines investigated, this enzyme is
localized to the nucleoplasm, consistent with its postulated
role in RNA processing. Although the cyclase has no appar-
ent sequence motifs in common with proteins of known
function, database searches indicated that genes encoding
proteins with significant similarity to the cloned human
enzyme are conserved among eucarya, bacteria and archaea
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[21]. Two different genes encoding cyclase-like proteins are
expressed in mammals and Drosophila (EB and WF; unpub-
lished observations). The protein encoded in the Escherichia
coli genome, which has 34% identity and 43% similarity to
the human cyclase, was found to have the RNA 3′-phos-
phate cyclase activity. The E. coli cyclase gene forms part of
a previously uncharacterized operon, expression of which is
controlled by an alternative sigma factor, σ54 [17,21].
The properties and substrate specificities of the human and
bacterial cyclases are nearly identical. The enzymes cyclize
the 3′-phosphate in RNAs with different sequences and
base composition, and trinucleotides appear to be the short-
est molecules able to act as substrates. With both enzymes,
the cyclization of the 3′-phosphate occurs in three steps:
first, Enzyme + ATP → Enzyme–AMP + PPi; second,
RNA-N3′p + Enzyme–AMP → RNA-N3′pp5′A + Enzyme;
third, RNA-N3′pp5′A → RNA-N>p + AMP. Evidence for
the first step comes from identification of the covalent
cyclase–AMP intermediates, whereas the second step is
supported by accumulation of the RNA-N3′pp5′A molecules
when the ribose at the RNA 3′ terminus is replaced 
with the 2′-deoxy- or 2′-O-methylribose. The third step
probably takes place non-enzymatically [17,20–23];
reviewed in [17,21,24].
Mechanistically, with respect to formation of the covalent
protein–NMP intermediate and a transfer of NMP to the
terminal phosphate in the nucleic acid, cyclase resembles
RNA and DNA ligases, as well as capping enzymes
(reviewed in [25]). In these enzymes, the nucleotidyl
group is transferred to the 5′-terminal phosphate or
pyrophosphate and a covalent lysyl–NMP intermediate is
formed, with the active-site lysine being present in a con-
served sequence motif, KxDG (in single-letter amino acid
code where x denotes any amino acid) [25]. At the molec-
ular level, however, the 3′-phosphate cyclization must
differ substantially from reactions catalyzed by ligases and
capping enzymes. The KxDG motif is not present in
cyclases, and we have found recently that the adenylyl
group transfer in the E. coli enzyme is transferred not to a
lysine but to a histidine [26].
The precise biological role(s) of cyclases is unknown.
Requirements for 2′,3′-cyclic phosphate ends in the sub-
strates of several eukaryotic and prokaryotic RNA ligases
suggest that the enzymes are involved in the generation
(or regeneration) of cyclic termini in RNA molecules
undergoing ligation. The cyclase could also be responsible
for producing 2′,3′-cyclic ends identified in the spliceoso-
mal U6 RNA [27] and a few other small RNAs [28]; for a
discussion of additional possible functions of cyclases see
[21]. The conservation of cyclases among eucarya, bacteria
and archaea argues that the enzymes must perform an
important function in RNA metabolism. This view is sup-
ported by the findings that the gene encoding cyclase in
the yeast Saccharomyces cerevisiae is essential for growth
(EB and WF, unpublished observations). 
Phylogenetic analysis of the E. coli and human cyclases,
and cyclase-like proteins encoded in other organisms,
indicated that cyclases can be subdivided into two classes
[26]. Members of class I include all prokaryotic proteins,
the Dictyostelium discoideum protein, and one of the two
proteins expressed in Drosophila and humans (Figure 1).
The previously characterized E. coli and human cyclases
belong to this class of enzymes. Class II proteins are
encoded by the genomes of budding and fission yeast, as
well as Caenorhabditis elegans, and are second forms of pro-
teins expressed in Drosophila and humans.
To gain further insight into the structure and biology of
the RNA 3′-phosphate cyclases, we have determined the
crystal structure of the E. coli enzyme, a member of the
class I family, and refined it with 2.1 Å resolution data.
The structure and its implications for the catalytic activity
are discussed here.
Results
Solution of the crystal structure
RNA cyclase from E. coli was crystallized in several forms.
Crystals of the selenomethionine (SeMet) protein in
form I (see the Materials and methods section) were used
to solve the structure using multiwavelength anomalous
diffraction (MAD). Crystals of form II of the native protein
diffracted better than those of form I and were used to
refine the structure to R = 20.4% (Rfree = 27.6%) at 2.1 Å
resolution. All detailed structural descriptions are made on
the basis of this crystal form. A molecular replacement
solution was obtained for crystal form III, proving that the
quaternary structure of dimers observed in the first two
crystal forms is conserved also in this crystal form.
The two monomers found in the asymmetric unit of form
II crystals produce a disulfide-linked dimer, through
Cys308 of each molecule. The electron density corre-
sponding to this link is very clear and its presence in the
crystals is unambiguous (Figure 2a). Only residues 5–338
were included in the model for both monomers, without
the four residues at the N terminus or the C-terminal His-
tag. Two citrate molecules, one of which is shown in
Figure 2b, and a dithiothreitol (DTT) moiety were
modeled in addition to the solvent molecules. The
Ramachandran plot for the model is of high quality, with
the exception of Ser95, which is part of one of the flexible
loops described below. 
Overall structure of RNA cyclase
A molecule of cyclase consists of two structurally distinct
domains, connected by two polypeptide chains (Figure 3a).
The larger domain (residues 1–184 and 280–339) consists
of three repeats of a folding unit comprising two α helices
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and a four-stranded β sheet in +1X,+ 2X,–1 topology [29],
with one of the parallel helices in each of the cross-over
connections. This type of folding motif is usually associ-
ated with the bacterial translation initiation factor 3 (IF3),
in which it comprises its C-terminal domain [30]. The
superposition of cyclase residues 5–87 on IF3 residues
84–170 yields a root mean square (rms) deviation of 3.0 Å
for 69 common Cα pairs.
The smaller domain of cyclase, residues 185–279, comprises
the same secondary structure elements — a four-stranded
β sheet covered by two parallel helices — but their connec-
tion topology (+1X,–2,–1) is different, corresponding to the
fold previously observed in human thioredoxin [31]. The
superposition of cyclase residues 185–279 on thioredoxin
residues 19–105 yields an rms deviation of 2.8 Å for 69
Cα pairs. Other proteins utilizing this motif are porpho-
bilinogen deaminase [32], glutathione S-transferase [33]
and riboflavin synthase [34]. The small domain is inserted
between an α helix and a β strand from the third IF3-like
repeat in the large domain (Figure 4).
The finding that in all crystal forms analyzed so far, E. coli
RNA cyclase is present as a covalent, disulfide-linked
dimer, was unexpected. Previous studies performed with
the purified human enzyme, which shows 34% sequence
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Figure 1
Alignment of proteins in the cyclase class I
subfamily: Pf, Pyrococcus furiosus (The
Institute for Genomic Research, Gaithersburg,
MD); Ph, Pyrococcus horikoshii (deposited in
the Entrez database as BAA30639); Af,
Archaeoglobus fulgidus (Entrez AAB89810);
Mj, Methanococcus jannaschii (SP Q60335);
Mt, Methanobacterium thermoautotrophicum
(Entrez AAB86375); Aa, Aquifex aeolicus
(Entrez AAC06852); Dd, Dictyostelium
discoideum (Entrez AAB70847; this protein
contains 29 additional N-terminal amino acids,
which are not shown); Hs1, Homo sapiens
(SP O00442); Dm1, Drosophila melanogaster
(SPTREMBL O77264); Pa, Pseudomonas
aeruginosa (The Pseudomonas Genome
Project; http://www.pseudomonas.com); Ec,
E. coli (SP P46849). Multiple sequence
alignment was performed with the Clustal
W1.5 program [62] using the complete
multiple alignment protocol with default
parameters. The alignment was improved
manually. Identical amino acids and amino
acids conserved in at least 50% of sequences
are indicated by black and gray boxes,
respectively. The histidine that undergoes
adenylation (His309 in the E. coli protein) is
marked with an asterisk, and hexameric
sequences that correspond to the motifs
Lxx(L)G(A), previously identified in MurA and
EPSP synthase (see text), are underlined.
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identity to the E. coli enzyme and has very similar require-
ments and substrate specificity [17,21], demonstrated that
it is present in solution in the form of a monomer [20].
Nevertheless, in the experimentally determined map, the
electron density for the disulfide bridge consisting of
Cys308 from two molecules is absolutely clear (Figure 2a).
A dimer was also indicated by dynamic light scattering
(AW, unpublished observations). The disulfide bridge
must be unique to E. coli cyclase, even if the quaternary
structure is conserved in cyclase from other organisms
because Cys308 is not conserved in the sequences of other
class I cyclases (Figure 1). Although we cannot rule out
the possibility that the disulfide bond is an artifact of
protein purification and crystallization, the identical qua-
ternary structure was observed in four crystallographically
independent dimers occurring in three crystal forms under
various conditions. Given that crystal forms I and II are
closely related, the arrangement of the dimers is therefore
similar in both forms, but nevertheless more divergent
than would be expected for stable higher oligomers. 
The two monomers of the dimer are related by a dyad
that can be noncrystallographic (as in crystal forms I and
II) or crystallographic (as in crystal form III). In crystal
form II, the two monomers (Figure 3b) have an rms devi-
ation of 0.40 Å between their Cα atoms. Similar compar-
isons would be meaningless for crystal form I because of
strong noncrystallographic symmetry (NCS) restraints
utilized during refinement. The rms deviations between
different monomers found in crystal forms I and II are, on
average, 0.56 Å. The rms deviation between the dimers,
0.65–1.20 Å, shows that the dimer interface is fairly rigid
and specific, despite its rather small area (~680 Å2). The
interface is formed by two symmetry-related β strands
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Figure 2
Representative electron-density maps. (a) The
original MAD map in the vicinity of Cys308,
contoured at the 1.0σ level, clearly shows the
disulfide bridge. Noncrystallographic
averaging was not used in the calculation of
the map shown here. (b) The final, refined
2.1 Å map (2Fo–Fc) in the vicinity of the citrate
molecule, contoured at the 1.0σ level. Note
the well-coordinated C-terminal carboxyl
groups of the citrate molecule, which might
mimic the backbone of substrate RNA. Atoms
are shown in standard colors.
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(residues 324–331) creating an eight-stranded β sheet
and by three loops (residues 12–14, 42–44 and 305–311),
and is mainly hydrophobic. Its size is more comparable to
the usual crystal contacts rather than to tight domain
interfaces.
Location of the active site
The identity of the residues forming the active site of
cyclase is largely unknown at this time. Sequencing of
proteolytic fragments of cyclase adenylylated with [α-32P]
ATP identified His309 as the labeled residue [26], leading
to its assignment to the active site. Covalent nucleotidyla-
tion of lysines and other amino acids has been described
either as part of the catalytic mechanism of nucleotidyl
transferases such as RNA-capping enzymes and DNA and
RNA ligases (reviewed in [25]), or as a mechanism to regu-
late the activity of proteins (reviewed in [35,36]), and uti-
lization of a histidine for these purposes has also been
reported [37,38]. In class I cyclases, His309 is completely
conserved, although it is not conserved in the structurally
related type II proteins [26].
When viewed in the three-dimensional structure, His309 is
located on the bottom of a large cleft and is surrounded by a
number of other strictly conserved residues (Figure 5).
Facing His309 are the five loops with the highest B factors
in the entire structure (mainchain atom B factors > 50 Å2;
9–16, 40–47, 93–97, 255–257, 328–333). At the same time,
many residues of these loops are highly conserved (28%
totally conserved residues compared with 14% overall in
class I cyclases). Other loops facing the solvent are much
better defined. One of the flexible loops includes the
stretch 14–21 (EGGGQILR), which is almost entirely con-
served in the 11 known sequences of class I cyclases. Glu14
in this stretch appears to form a strong hydrogen bond with
the Nδ1 of His309 (distance ~2.7 Å), and Gln18, a very
weak one with Nε2. Other neighboring residues include the
mostly conserved Tyr284 (replaced only by other aromatic
residues, phenylalanine or histidine), strictly conserved
Asp287 (which is on the opposite side of the ring of His309),
Ser307 (its only replacement is a threonine) and slightly less
conserved Asn313. The citrate bound in crystal form II is
liganded by Gly17, Arg21, Arg40, Arg43, Gln51 and His52.
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Figure 3
Stereo diagrams of the backbone of RNA
cyclase. (a) Ribbon representation of the
crystal structure of a single cyclase molecule
and the atomic surface of the protein. The
chain corresponding to the large domain is
shown in blue and the small domain is shown
in pink. The sidechain of His309 is shown in
red. (b) A noncrystallographic dimer of RNA
cyclase, with two molecules shown in green
and gold. Sidechains of His309 are rendered
in atomic colors and the citrate molecules are
shown in space-filling representation.
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Comparison with other enzymes 
A search of the database of all unique structures per-
formed with the program DALI [39] did not identify any
other proteins with the complete fold corresponding to
that of cyclase. However, each individual domain of the
cyclase, as defined above, has shown similarity to at least
some domains found in other proteins. Most striking is the
similarity of the larger domain of cyclase to a single domain
found in two structurally related proteins, UDP–N-acetyl-
glucosamine enolpyruvyl transferase (MurA) [40,41] and
5-enol-pyruvylshikimate-3-phosphate synthase (EPSP
synthase) [42]; see Figure 4). Each of these proteins con-
sists of two domains that are topologically equivalent and
structurally similar to each other. Thus, each of the
domains of MurA and EPSP synthase is not only com-
pletely topologically equivalent to the large domain of
cyclase but also similar in direct comparison of the coordi-
nates. The rms deviation between the Cα coordinates of
residues 22–216 in MurA [41] and residues 5–184 and
280–328 in cyclase is 3.0 Å for 185 atom pairs, and a similar
comparison with the recently refined coordinates of EPSP
synthase (K Brown, personal communication) yielded an
rms deviation of 2.9 Å for 186 atom pairs.
A common feature observed, without exception, in all six
IF3 motifs in both MurA and EPSP synthase is a hexapep-
tide with the sequence Lxx(L)G(A), connecting these
motifs into trimers [40–42]. Although leucine and glycine
(the latter with positive φ/ψ angles) are always found in
positions 1 and 5, respectively, positions 4 and 6 are seldom
mutated, and positions 2 and 3 are usually occupied by
hydrophobic residues. A comparison of the structurally
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Figure 4
Topology diagram of RNA cyclase and a
comparison with EPSP synthase [42].
Secondary structure elements forming
compact folding units are solid and those not
adjacent in the primary structure are marked
as open arrows. (a) Two domains of RNA
cyclase, with the larger domain 1 including
both the N and C termini. (b) EPSP synthase,
adapted from [42]. Although the domain
designation of the two proteins is reversed,
the similarity of domain 1 of cyclase to domain
2 of EPSP synthase, including the location of
the non-contiguous secondary structure
element, is clear.
Figure 5
Stereo diagram of the putative active site of
RNA cyclase. Conserved residues found
within 10 Å of His309 are shown in green and
the mostly conserved Tyr284 and Leu285
residues are in brown. The sidechain of the
non-conserved Cys308, which makes a
disulfide bridge, is also marked. 
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aligned cyclase sequences shows that a similar structure is
found in at least two out of three IF3-like motifs. In motif
1, the corresponding sequence is TEICGA (residues
60–65) and it superimposes very well on its counterparts in
MurA and EPSP synthase. This sequence does not appear
to be well conserved in other class I cyclases; in particular,
glycine is substituted for the most part by asparagine
(Figure 1). The alignment of the sequence found in the
motif 2 is shifted by one residue but the sequence itself
still has some visible similarity to that of the consensus
sequence. The cyclase residues 144–149 are LAKIGI and
the glycine torsion angles are similar to those found in the
equivalent peptides in the other two proteins. Conserva-
tion of this sequence in other class I cyclases is quite high,
with glycine present in all of the cyclases except for one.
Finally, the ERFLPV sequence present in a similar posi-
tion in motif 3 (residues 318–323) is quite different. It
does, however, have some similarity, given that the
replacement of glycine by proline is quite common, and
the nature of most other residues in this sequence bears at
least some relation to their counterparts in the other motifs.
In almost all of the other class I cyclases, the proline
residue is indeed aligned with glycine.
Discussion
Comparison with other enzymes
The primary structures of the human and E. coli cyclases
have been determined only recently [17,21]. Although
cyclase homologs have been found in organisms belong-
ing to all kingdoms, no other proteins seemed to be obvi-
ously related to cyclase. Thus, no structure could be
predicted, making cyclase an interesting target for struc-
ture determination by experimental means. It was also
hoped that the availability of the structure would provide
some clues to the function of the protein, as has been
shown in other cases [43].
As expected, the complete fold of cyclase does not corre-
spond to any known proteins. Because the collection of the
protein domains is being completed faster than that of the
folds, however, it is not surprising that both domains of
cyclase have been identified as parts of other proteins.
Most prominently, the large domain with approxi-
mately240 residues appears twice in each of two related
enzymes, MurA and EPSP synthase. The completely con-
served topology of this rather large domain clearly indicates
a common ancestor, but domain arrangement and sub-
strates have since diverged. The monomers in cyclase and
in the two domains in the other two enzymes create differ-
ent clefts containing the putative or actual active sites. The
substrates, too, are very different: ATP and RNA for
cyclase; phosphoenolpyruvate (PEP) and UDP–GlcNAc
for MurA; and PEP and 3-phosphoshikimate for EPSP syn-
thase. The strong divergence is obvious at the sequence
level. Only careful searches performed with Ψ–BLAST
[44] reveal a weak similarity between cyclase and EPSP
synthase. In a recent structure prediction exercise with
knowledge of only the sequence, the best models built had
an rms deviation of 4 Å for only 100 amino acids [45], but
the choice of a proper lead model was by no means
obvious. The small domain is structurally similar to
domains in riboflavin synthase, glutathione S-transferase
and porphobilinogen deaminase. Similarly to what was
observed for the large domain, none of these structurally
related enzymes is functionally related to cyclase. 
As outlined above, both domains of cyclase in their
present form have diverged so far from proteins with
similar domains that functional relationships have been
lost. The larger domain is built up by a threefold repeat of
an ancestral structural motif that appears in several nucleic
acid binding proteins: the C-terminal domain of IF3 [30],
DNase I [46], DNA methyltransferase [47], the N-termi-
nal domain of ribosomal protein S8 [48], and the single-
stranded nucleic acid binding motif R3H that has a
characteristic Arg/His pair separated by three residues
[49]. The course of evolution could thus have proceeded
from an RNA-binding protein with one repeat to cyclase
with three repeats and finally to MurA/EPSP synthase
with six repeats and with new substrates. 
The active site of cyclase
The location of the active site of cyclase cannot yet be
specified precisely, because the structure presented here
does not include any bound substrate. We predict that the
active site will cover a fairly large area, for at least two
reasons. First, the RNA substrate is itself rather large (at
least three nucleotides are required), and second, possibly
different residues might be involved in catalyzing at least
two separate reactions, the first and second steps, outlined
in the Introduction. Analysis of the adenylated protein
showed that the reaction product of the first step, adeny-
lated His309, is part of the active site. This residue is
located at one end of a long cleft located between the large
and small domains of the enzyme. All of the surrounding
conserved residues belong to the same molecule of cyclase
(Figure 5), although the putative active site is in the vicin-
ity of the dimer interface created through the formation of
an intermolecular disulfide bond by Cys308 of two mole-
cules. This bond might be the native redox state of the cys-
teines, even in the reducing environment of the cytosol,
because it is observed despite purification and crystalliza-
tion in the presence of DTT. Several protein loops located
in the vicinity of His309 contain many conserved residues,
but also display above-average B factors. These flexible
parts of the enzyme might become well ordered only upon
binding of the substrate(s) and might be necessary to move
the products to new locations, to become substrates in sub-
sequent steps of the overall reaction. 
The citrate molecule bound to cyclase in crystal form II
(Figures 2a,3b) is coordinated by three arginines, a histidine
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or glutamine, and a mainchain nitrogen, fitting this site very
well. The distance between the two terminal carboxylates
(5.2 Å) might mimic the spacing of the phosphate groups in
an RNA backbone (5.9 Å), but we cannot postulate which
part of the substrate might be mimicked by the citrate. The
distance between His309 and the closest carboxylate of the
citrate is approximately 6 Å. In addition, the second step of
the reaction involves not a histidine, but rather its adeny-
lated form, making more precise assignments of the loca-
tion of the groups participating in the reaction impossible.
Only by determining the structure of an RNA complex of
cyclase will it be possible to delineate the precise location
of the substrate.
Indirect evidence supporting the location of the active site
in the large, open channel that includes His309 is pro-
vided by the comparison of cyclase with the structurally
related enzymes MurA and EPSP synthase. The large
domain of cyclase can be superimposed on the catalytic
domain of MurA such that the two ligands of the latter
enzyme, the inhibitor fosfomycin and UDP–GlcNAc [41],
bind to the enzyme’s surface corresponding to the general
area of His309 (although the pseudo-threefold symmetry
axis within the domain allows for three different equiva-
lently valid superpositions). It is commonly accepted that
within superfolds, binding sites are similar even in the
absence of homology [50], and even more so when weak,
but discernible homology is present, as is the case here.
Although no ligand-bound structures of EPSP synthase
are available at this time, it is also probable that its cat-
alytic site is located in the equivalent area (K Brown, per-
sonal communication). It should also be pointed out that
both MurA and EPSP synthase, in common with cyclase,
bind multiple phosphate groups during their catalytic
cycles. These indirect indications support the proposed
location of the active site of cyclase, even though they do
not provide complete proof of such an assignment.
E. coli cyclase is the only protein that has been unambigu-
ously shown to be adenylated on a histidine in a stable
manner, and to use ATP as a cofactor [26]. Enzymes from
the histidine triad (HIT) family have been shown to form
covalent adenylated intermediates; the involvement of a
histidine in the linkage has not been demonstrated
directly (although structures of transition-state analogs
involving adenosine–tungstate covalently attached to his-
tidine have been described [38]). Three other proteins
known to undergo modification on a histidine residue with
nucleotidyl groups other than an adenylyl group are galac-
tose-1-phosphate uridylyltransferase [37,51], the Gag
protein of the S. cerevisiae double-stranded RNA L-A virus
[52] and the brine shrimp GTP–GTP guanylyltransferase
[53]. The tertiary structure has been established only in
the case of the galactose-1-phosphate uridylyltransferase.
This enzyme, which is involved in the Leloir pathway for
galactose metabolism, is transiently uridylated on Nε2 of
the imidazole ring of a histidine; UDP–glucose is a uridyl
group donor in this reaction [37,51].
An analysis of the residues interacting with the nucleotide
in the modified galactose-1-phosphate uridylyltransferase
points to some potentially important similarities with
cyclase. In particular, one of the phosphate oxygens inter-
acts with the sidechain of a glutamine. We speculate that
Gln18, a residue completely conserved in class I cyclases,
might play a similar role because it is located in the vicin-
ity of the adenylation site but does not show strong inter-
actions with His309 in the apoenzyme. It can be shown by
modeling that if the binding of an adenylate group is
similar to that of uridylate in galactose-1-phosphate uridy-
lyltransferase, Gln18 could reorient and make equivalent
interactions. The residue interacting directly with the his-
tidine sidechain is serine in galactose-1-phosphate uridy-
lyltransferase, which might be substituted in cyclase by
the similarly conserved Glu14 (Figure 5).
A question that remains unanswered is the structural rela-
tionship between class I and class II cyclases. Although the
sequence comparison of these two classes shows that they
share similar overall structure, the most striking difference
between them is the lack of conservation of His309. Prelim-
inary modeling of class II cyclases based on the structure of
class I E. coli cyclase described here has shown the feasibil-
ity of creating reasonable models, with the most difficulty
encountered in modeling the third folding unit of domain 1
(Figure 4), which includes His309. The remaining ques-
tions about the enzymatic mechanism of cyclases can,
therefore, be answered only by an experimentally deter-
mined structure of a class II cyclase, as well as structures of
substrate complexes of both class I and class II proteins.
Biological implications
Anabolic function of the 2′,3′-cyclic phosphate in RNA
first emerged when it was found that eukaryotic and
prokaryotic RNA ligases require 2′,3′-cyclic ends for
RNA ligation. Such ends can be produced by the cleav-
age of longer RNA molecules by endonucleases or by
ATP-dependent conversion of the 3′-monophosphate at
the end of RNA into the cyclic diester. The latter reac-
tion is catalyzed by the RNA 3′-terminal phosphate
cyclase, a ubiquitous enzyme conserved among eucarya,
bacteria and archaea. The crystal structure of
Escherichia coli cyclase reported here, indicates that
cyclases are not structurally related to RNA processing
enzymes such as RNA and DNA ligases and capping
enzymes. Despite this, mechanistically, reactions cat-
alyzed by these enzymes and the cyclase are similar. In
contrast, and rather unexpectedly, the cyclase has
common origin with two enzymes that are not involved in
RNA metabolism: MurA and EPSP synthase. These
two enzymes, however, are similar to cyclase in that all
20 Structure 2000, Vol 8 No 1
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of them bind multiple phosphate groups during their cat-
alytic cycles.
Identification of the probable active site of RNA
cyclase, which includes the conserved amino acid
residues His309, Glu14, Gln18 and Asp287, will greatly
facilitate further investigation of the function of the
protein, by construction of negative dominant mutants
and other approaches. A long cleft adjacent to these
conserved residues forms the putative binding site for
the large RNA substrate. The established structure of
the E. coli protein, a class I enzyme, will also permit
modeling and rational mutagenesis of class II cyclases
that have so far resisted crystallization (AW, unpub-
lished observations). This should allow us to test directly
whether or not the observed essential presence of the
class II proteins for growth in the yeast Saccharomyces
cerevisiae (EB and WF, unpublished observations) is
indeed dependent upon enzymatic competence of the
protein.
Materials and methods
Protein expression, purification and crystallization
E. coli cyclase was bacterially overexpressed as a fusion protein with a
GSHHHHHH peptide at the C terminus, using a pET-11d vector-
based expression plasmid [17,21]. The overexpressed protein was
purified by metal affinity chromatography, using a Ni2+-NTA column
(Qiagen), and desalted on a PD10 column into 50 mM Hepes pH 7.6,
100 mM NaCl, 0.1 mM EDTA, 0.5 mM DTT, 5% glycerol. The protein
solution was stored and transported at –70°C. SeMet-labeled protein
was expressed from the same vector, but using B834(DE3) cells
(methionine auxotroph). The change to the SeMet expression system
lowered the protein yield at least 50-fold to 0.2 mg of purified protein
per liter of cell culture.
Crystallizations were carried out using the hanging-drop vapor diffusion
technique at 20°C. The stock protein solution was concentrated to
approximately 15 mg/ml. The well solution contained 13–15% MPEG
2000, 200 mM Na citrate pH 4.0, 200 mM Tris-HCl pH 8.0, 2 mM DTT
(resulting pH ~5.5). Drops of 2 µl protein solution plus 2 µl of well solu-
tion were equilibrated against the well solution. Two closely related,
orthorhombic crystal forms of similar morphology were observed
growing together. One of them (form I) was later identified as belong-
ing to space group P212121, a = 101.8 Å, b = 126.6 Å, c = 128.8 Å,
with four molecules in the asymmetric unit, whereas the other (form II)
was in space group P21212, a = 125.8 Å, b = 133.5 Å, c = 51.0 Å, with
two molecules in the asymmetric unit. Because it was not possible to
distinguish between these two crystal forms on the basis of appear-
ance only, each crystal used for data collection had to be characterized
separately. The buffers in the well solution could be replaced by high
salt (600–900 mM NaCl, 300 mM ammonium sulfate, 800 mM KCl, or
400 mM LiCl), giving lower quality crystals in yet other space groups
(in particular, form III, grown with NaCl, belongs to space group C2221
with the unit-cell parameters a = 47.9 Å, b = 92.2 Å, c = 144.0 Å). The
addition of Mg2+, known to be required for the catalytic activity of RNA
cyclase, did not have any visible effect on crystal growth. Attempts to
cocrystallize cyclase with ATP analogs and/or with oligoribonucleotide
substrates have so far not been successful, nor could such complexes
be made by soaking the crystals.
Data collection
Diffraction data were collected on beamline X9B at the NSLS synchro-
tron source at Brookhaven National Laboratory. Reflection intensities
were measured with a MAR345 image plate detector and processed
with the HKL2000 suite of programs [54]. Prior to data collection, the
crystals were rapidly frozen in a stream of cold nitrogen (100K) pro-
vided by an Oxford Cryosystems device, after being briefly drawn
through the mother liquors with half and full concentrations of cryopro-
tectant (13% MPEG2000 replaced by 26% PEG200). MAD data
were collected to a maximum resolution of 2.8 Å from a single, ran-
domly oriented form I crystal at four wavelengths in 97.5° wedges
each: 0.97981 Å (edge), 0.97842 Å (peak), 1.02021 Å (remote), and
0.96 Å (second remote). Only a single data set was collected to the
maximum resolution of 2.1 Å from a form II crystal at the wavelength
0.96456. The details of data collection and processing are summa-
rized in Table 1. A further data set, not used for subsequent refine-
ment, was collected for a form III crystal to 2.6 Å resolution (Rigaku
RU-200 generator, Bruker HiStar multiwire detector, room tempera-
ture, Rsym 12.8%, 80.4% complete). Data for a native form I crystal
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Table 1
Results of crystallographic data collection and processing, and phasing statistics.
Selenomethionine derivative Native
Edge Peak Remote
Wavelength (Å) 0.97981 0.97942 1.02012 0.96456
No. of reflections* 161,894 (15,228) 162,741 (15,313) 154,068 (11,162) 159,690 (11,690)
Unique reflections*† 41,451 (4,084) 41,596 (4,074) 40,955 (3,233) 50,057 (4,214)
Resolution (Å) 20.0–2.8 20.0–2.8 20.0–2.8 20–2.1
Rmerge*‡ 0.043 (0.209) 0.045 (0.198) 0.042 (0.224) 0.043 (0.268)
Completeness (%)*† 99.9 (99.8) 99.9 (99.7) 97.8 (78.7) 97.2 (83.4)
Completeness (%)*§ 96.8 (91.4) 96.9 (91.6) 94.7 (72.2) 93.6 (76.5)
Phasing power#/RCullis¶ 1.44/0.628 1.77/0.581
SeMet derivative crystals were in space group P212121 (form I) with
unit-cell dimensions a=101.8, b=126.6, c=128.8 and four molecules
per asymmetric unit. The native crystals were in space group P21212
(form II) with unit-cell dimensions a=125.8, b=133.5, c=51.0 and two
molecules per asymmetric unit. Mean overall figure of merit 0.572
(0.817 after solvent flattening). *Last shell (2.9–2.8 Å for crystal form I,
2.17–2.1 Å for form II). †Reflections with I/σ(I) > –3.0. §Reflections with
I/σ(I) > 0. ‡Rmerge = ΣhΣi|I(h,i) – <I(h)>|/ΣhΣiI(h,i), where I(h,i) is the
intensity of the ith measurement of h and <I(h)> is the corresponding
value of I(h) for all i measurements. #Phasing power = <FH>/E, where
<FH> is the rms heavy-atom structure factor and E is the residual lack-
of-closure error (the remote data set is considered to be native). ¶RCullis
= Σ||FPH ± FP| – |FPH(calc)||/Σ|FPH – FP|, where FPH and FPH(calc) are the
observed and calculated structure factors of a heavy-atom derivative. 
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were also collected (MAR345 at Brookhaven, beamline X9B, 100K,
3.0 Å resolution, 93.2% complete, Rsym 6.9%), whereas each of the
seven useful SeMet cyclase crystals characterized during the course
of this work belonged to form I (no form II crystals were ever found for
the modified protein).
Structure solution
The structure was solved using multiwavelength anomalous diffraction
of the SeMet derivative. Comparison of the different crystal forms
clearly suggested a tetramer in the asymmetric unit of form I
(VM = 2.74 Å3/Da). Excluding the N-terminal methionine of each chain,
16 selenium atoms were thus expected in the SeMet derivative (in
place of residues Met5, Met28, Met191 and Met292). SHELXS [55]
was used for a direct methods search of the Se sites in the anomalous
and dispersive signal. The dispersive signal between either
λedge/λlow energy remote or λpeak/λlow energy remote yielded 12 sites. These
three wavelengths were used for all further calculations in PHASES
[56]. Difference Fourier maps based on the first 12 sites revealed four
more sites. The 16 sites could be grouped into four repeating units
with four selenium atoms each, confirming the four molecules per
asymmetric unit. They also obeyed the noncrystallographic translation
(0.500, 0.000, 0.042) predicted by a strong non-origin peak (35% of
the origin peak) in the native Patterson map. The deviation from higher
symmetry (as expected for perfect (1/2, 0, 0) translation) is sufficient to
obscure any trends in the intensity distribution. Solvent flattening
(Figure 2a) and fourfold noncrystallographic averaging resulted in inter-
pretable maps. All but the first four and the last nine residues (6× His-
tag and a connecting linker) could be traced.
Refinement
The protein model was refined with X-PLOR 3.1 [57] from R = 48.8%
(Rfree = 48.1%) to R = 23.7% (Rfree = 33.2%) using noncrystallographic
restraints (weight 100) (Table 2). At this point, no significant further
improvement was expected and the coordinates of one monomer were
used as a molecular replacement model for solving the structure of
crystal form II, to enable refinement with higher resolution data. A
straightforward solution was obtained in AMoRe [58] (data used
15–3.5 Å, correlation coefficient 64.5%, R factor 34.5%; wrong solu-
tions were eliminated in the rotation function search, because their
rotation function values were less than 50% of the correct solution).
The resulting model for form II with the two crystallographically inde-
pendent monomers has the same quaternary structure as the dimers in
form I. Refinement of this model was performed with the program
REFMAC [59]. Water molecules were added according to the Fo–Fc
map. NCS restraints were omitted in the later stages of the refinement.
A citrate ion was identified in each monomer close to Arg21, Arg40,
Arg43, Gln51 or His52, and the mainchain nitrogen of Gly17. Another
contiguous stretch of density could tentatively be described as oxidized
DTT, but was seen only in one monomer. This led to a model with R =
20.4% (Rfree = 27.6%) with good geometry (over 93% of all residues in
the most favorable region in the Ramachandran plot, with only Ser95 in
the generously allowed/disallowed region as assigned by PROCHECK
[60]; Table 2). The parts of the structure found in the lowest quality
regions were the loops close to the internal dyad around residues 14,
42 and 330 and two loops facing the cleft (around residues 95 and
256). Omit maps for the region 94–97 resulted in well defined contigu-
ous density; nevertheless, no definite conformation could be modeled
from this density, despite numerous trials. The buried surface of the
interface was calculated by subtracting the accessible surface of the
dimer from the sum of monomer surfaces with GRASP [61], omitting all
solvent molecules in the calculations.
The structure of crystal form III was solved with AmoRe [58] (data used
15–3.5 Å, correlation coefficient 64.7%, R factor 36.3%; best wrong
solution: correlation coefficient 44.2%, R factor 44.4%), but no further
refinement was performed.
Accession numbers
The final coordinates and structure factors have been deposited with the
PDB (accession code 1qmi for crystal form I and 1qmh for crystal form II).
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